Endo 2 Flashcards
normal blood glucose concentration
4.4-6.1
criteria for diagnosis of DKA
glucose >11
ketones >3
ph <7.3
how are fluids given in DKA
1 litre in first hour
then 1 litre every 2 hours
how is insulin given in DKA
fixed rate IV infusion at 0.1 units/kg/hr
when is a glucose infusion started in DKA
when glucose falls to <14 mmol/L
what is the normal maximum rate for insulin infusion
10 mmol/hour
macrovascular complications of diabetes
stroke
hypertension
CAD
peripheral ischaemia
microvascular complications of diabetes
peripheral neuropathy
retinopathy
kidney disease
what skin change is seen in type 2 diabetes
acanthosis nigricans- darkening and thickening of the skin at the neck axilla and groin
associated with insulin resistance
pre diabetes HbA1c
42-47 mmol/L
how often is HbA1c monitored in T2DM
every 3-6 months until stable
when are GLP-1 mimetics used in T2DM
when triple therapy fails and BMI>35
metformin moa
increases insulin sensitivity
decreases glucose production
main 2 side effects of SGLT-2 inhibitors
increased UTIs and thrush
DKA
SGLT-2 inhibitor moa
reduces glucose reabsorption in the kidney
pioglitazone moa
increases insulin sensitivity
decreases liver production of glucose
sulfonylurea moa
stimulate insulin release from pancreas
side effects of sulfonylureas
weight gain
hypoglycaemia
what is GLP-1 and what does it do
an incretin
they increase insulin release, inhibit glucagon production